Article info
PDFOriginal articles
Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants
- Correspondence to Omer Erdeve, 312 Ulusoy City, 16B/46, 2432. Cadde Agacseven Sokak, 06810, Cayyolu, Ankara, Turkey; omererdeve{at}yahoo.com
Citation
Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants
Publication history
- Received June 26, 2011
- Accepted November 2, 2011
- First published December 5, 2011.
Online issue publication
October 26, 2017
Article Versions
- Previous version (26 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions